drugset / Trial / NCT00881686

Myocardial Protection With Adenosine Preconditioning

NCT00881686

Phase 1/2 Completed 238 enrolled Xijing Hospital
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Adenosine has been proved to be an important mediator of myocardial protection induced by ischemic preconditioning. The hypothesis of this study is that adenosine preconditioning can provide additional myocardial protection in the setting of pediatric open heart surgery with cardioplegia and cardiopulmonary bypass.

Timeline

Start
2008-06
Primary completion
2008-12
Completion
2008-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Adenosine Small molecule 1.5 mg/kg Intravenous